The 2nd International Congress on Immunopharmacology was held in June of 2011 at the Conference Center of Plaza America in Varadero, Cuba. The main goal of this meeting was to provide state-of-the-art communications for scientists, manufacturers, regulators and healthcare workers, to accelerate progress in the development of biological and biotechnological products and to promote exchange/scientific cooperation between researchers. 300 delegates from 22 countries attended the conference. The wide-ranging programme commenced with a plenary session and then split into a series of parallel workshops and symposia, covering “Advances in Immunopharmacology”, “Neuroimmunology”, “Therapeutic Biological Products”, “Prophylaxis and Treatment of Helicobacter pylori”, “Pharmacology of Cytochrome P450”, “Hereditary Ataxias” and “Delivery Systems and Current Strategies for Drug Design”. In this last Symposium, a substantial body of data was presented relating to the development of delivery systems with adjuvant and vaccine potential and also to strategies focused in therapeutic and prophylactic approaches against tuberculosis. This issue is dedicated to some of the results presented in this area.
|Number of pages||2|
|Issue number||Supplement 1|
|Publication status||Published - 25 Feb 2013|
|Event||Second International Congress on Immunopharmacology 2011 - Conference Center of Plaza America, Varadero, Cuba|
Duration: 26 Jun 2011 → 30 Jun 2011
- drug design
Acevedo, R., Landys, M., Acosta, A., Bercovier, H., Norazmi, M. N., Ferro, V., & Sarmiento, M. E. (2013). Second international congress on immunopharmacology: delivery systems and current strategies for drug design. BMC Immunology, 14(Supplement 1), [S1]. https://doi.org/10.1186/1471-2172-14-S1-S1